ARCTURUS THERAPEUTICS HOLDINGS INC. Proceeds from Issuance or Sale of Equity
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Proceeds from Issuance or Sale of Equity of $21.40 million for the 3-month period ending 2019-09-30, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2020-03-16
- ARCTURUS THERAPEUTICS HOLDINGS INC. proceeds from issuance or sale of equity for the quarter ending 2019-09-30 was $21.40M.
| Period end | Proceeds from Issuance or Sale of Equity 3 month |
|---|---|
| 2019-09-30 | $21.40M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |